Evidence-Based Oncology Zaia Draws on Decades of Innovation in Infectious Disease for Breakthroughs in Gene Therapy
June 17, 2020
By Interview by Maggie L. Shaw
Known as a gene therapy pioneer, Zaia has spent almost 40 years at City of Hope, in Duarte, California. He was first drawn by the promise of studying cytomegalovirus. Over the decades, his groundbreaking research has encompassed HIV/AIDS, cellular gene transfer therapy, immunotherapy, bispecific antibodies, and now hyperimmune globulin for workers on the frontlines of the coronavirus disease 2019 (COVID-19) pandemic.